Cargando…

Incidence, clinical course and risk factor for recurrent PCR positivity in discharged COVID-19 patients in Guangzhou, China: A prospective cohort study

The phenomenon of COVID-19 patients tested positive for SARS-CoV-2 after discharge (redetectable as positive, RP) emerged globally. The data of incidence rate and risk factors for RP event and the clinical features of RP patients may provide recommendations for virus containment and cases management...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Jiazhen, Zhou, Rui, Chen, Fengjuan, Tang, Guofang, Wu, Keyi, Li, Furong, Liu, Huamin, Lu, Jianyun, Zhou, Jiyuan, Yang, Ziying, Yuan, Yuxin, Lei, Chunliang, Wu, Xianbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505432/
https://www.ncbi.nlm.nih.gov/pubmed/32866168
http://dx.doi.org/10.1371/journal.pntd.0008648
_version_ 1783584810788192256
author Zheng, Jiazhen
Zhou, Rui
Chen, Fengjuan
Tang, Guofang
Wu, Keyi
Li, Furong
Liu, Huamin
Lu, Jianyun
Zhou, Jiyuan
Yang, Ziying
Yuan, Yuxin
Lei, Chunliang
Wu, Xianbo
author_facet Zheng, Jiazhen
Zhou, Rui
Chen, Fengjuan
Tang, Guofang
Wu, Keyi
Li, Furong
Liu, Huamin
Lu, Jianyun
Zhou, Jiyuan
Yang, Ziying
Yuan, Yuxin
Lei, Chunliang
Wu, Xianbo
author_sort Zheng, Jiazhen
collection PubMed
description The phenomenon of COVID-19 patients tested positive for SARS-CoV-2 after discharge (redetectable as positive, RP) emerged globally. The data of incidence rate and risk factors for RP event and the clinical features of RP patients may provide recommendations for virus containment and cases management for COVID-19. We prospectively collected and analyzed the epidemiological, clinical and virological data from 285 adult patients with COVID-19 and acquired their definite clinical outcome (getting PCR positive or not during post-discharge surveillance). By March 10, 27 (9.5%) discharged patients had tested positive for SARS-CoV-2 in their nasopharyngeal swab after a median duration of 7·0 days (IQR 5·0–8·0). Compared to first admission, RP patients generally had milder clinical symptoms, lower viral load, shorter length of stay and improved pulmonary conditions at readmission (p<0.05). Elder RP patients (≥ 60 years old) were more likely to be symptomatic compared to younger patients (7/8, 87.5% vs. 3/19, 18.8%, p = 0.001) at readmission. Age, sex, epidemiological history, clinical symptoms and underlying diseases were similar between RP and non-RP patients (p>0.05). A prolonged duration of viral shedding (>10 days) during the first hospitalization [adjusted odds ratio [aOR]: 5.82, 95% confidence interval [CI]: 2.50–13.57 for N gene; aOR: 9.64, 95% CI: 3.91–23.73 for ORF gene] and higher Ct value (ORF) in the third week of the first hospitalization (aOR: 0.69; 95% CI: 0.50–0.95) were associated with RP events. In conclusion, RP events occurred in nearly 10% of COVID-19 patients shortly after the negative tests, were not associated with worsening symptoms and unlikely reflect reinfection. Patients’ lack of efficiency in virus clearance was a risk factor for RP result. It is noteworthy that elder RP patients (≥ 60 years old) were more susceptible to clinical symptoms at readmission.
format Online
Article
Text
id pubmed-7505432
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-75054322020-09-30 Incidence, clinical course and risk factor for recurrent PCR positivity in discharged COVID-19 patients in Guangzhou, China: A prospective cohort study Zheng, Jiazhen Zhou, Rui Chen, Fengjuan Tang, Guofang Wu, Keyi Li, Furong Liu, Huamin Lu, Jianyun Zhou, Jiyuan Yang, Ziying Yuan, Yuxin Lei, Chunliang Wu, Xianbo PLoS Negl Trop Dis Research Article The phenomenon of COVID-19 patients tested positive for SARS-CoV-2 after discharge (redetectable as positive, RP) emerged globally. The data of incidence rate and risk factors for RP event and the clinical features of RP patients may provide recommendations for virus containment and cases management for COVID-19. We prospectively collected and analyzed the epidemiological, clinical and virological data from 285 adult patients with COVID-19 and acquired their definite clinical outcome (getting PCR positive or not during post-discharge surveillance). By March 10, 27 (9.5%) discharged patients had tested positive for SARS-CoV-2 in their nasopharyngeal swab after a median duration of 7·0 days (IQR 5·0–8·0). Compared to first admission, RP patients generally had milder clinical symptoms, lower viral load, shorter length of stay and improved pulmonary conditions at readmission (p<0.05). Elder RP patients (≥ 60 years old) were more likely to be symptomatic compared to younger patients (7/8, 87.5% vs. 3/19, 18.8%, p = 0.001) at readmission. Age, sex, epidemiological history, clinical symptoms and underlying diseases were similar between RP and non-RP patients (p>0.05). A prolonged duration of viral shedding (>10 days) during the first hospitalization [adjusted odds ratio [aOR]: 5.82, 95% confidence interval [CI]: 2.50–13.57 for N gene; aOR: 9.64, 95% CI: 3.91–23.73 for ORF gene] and higher Ct value (ORF) in the third week of the first hospitalization (aOR: 0.69; 95% CI: 0.50–0.95) were associated with RP events. In conclusion, RP events occurred in nearly 10% of COVID-19 patients shortly after the negative tests, were not associated with worsening symptoms and unlikely reflect reinfection. Patients’ lack of efficiency in virus clearance was a risk factor for RP result. It is noteworthy that elder RP patients (≥ 60 years old) were more susceptible to clinical symptoms at readmission. Public Library of Science 2020-08-31 /pmc/articles/PMC7505432/ /pubmed/32866168 http://dx.doi.org/10.1371/journal.pntd.0008648 Text en © 2020 Zheng et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Zheng, Jiazhen
Zhou, Rui
Chen, Fengjuan
Tang, Guofang
Wu, Keyi
Li, Furong
Liu, Huamin
Lu, Jianyun
Zhou, Jiyuan
Yang, Ziying
Yuan, Yuxin
Lei, Chunliang
Wu, Xianbo
Incidence, clinical course and risk factor for recurrent PCR positivity in discharged COVID-19 patients in Guangzhou, China: A prospective cohort study
title Incidence, clinical course and risk factor for recurrent PCR positivity in discharged COVID-19 patients in Guangzhou, China: A prospective cohort study
title_full Incidence, clinical course and risk factor for recurrent PCR positivity in discharged COVID-19 patients in Guangzhou, China: A prospective cohort study
title_fullStr Incidence, clinical course and risk factor for recurrent PCR positivity in discharged COVID-19 patients in Guangzhou, China: A prospective cohort study
title_full_unstemmed Incidence, clinical course and risk factor for recurrent PCR positivity in discharged COVID-19 patients in Guangzhou, China: A prospective cohort study
title_short Incidence, clinical course and risk factor for recurrent PCR positivity in discharged COVID-19 patients in Guangzhou, China: A prospective cohort study
title_sort incidence, clinical course and risk factor for recurrent pcr positivity in discharged covid-19 patients in guangzhou, china: a prospective cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505432/
https://www.ncbi.nlm.nih.gov/pubmed/32866168
http://dx.doi.org/10.1371/journal.pntd.0008648
work_keys_str_mv AT zhengjiazhen incidenceclinicalcourseandriskfactorforrecurrentpcrpositivityindischargedcovid19patientsinguangzhouchinaaprospectivecohortstudy
AT zhourui incidenceclinicalcourseandriskfactorforrecurrentpcrpositivityindischargedcovid19patientsinguangzhouchinaaprospectivecohortstudy
AT chenfengjuan incidenceclinicalcourseandriskfactorforrecurrentpcrpositivityindischargedcovid19patientsinguangzhouchinaaprospectivecohortstudy
AT tangguofang incidenceclinicalcourseandriskfactorforrecurrentpcrpositivityindischargedcovid19patientsinguangzhouchinaaprospectivecohortstudy
AT wukeyi incidenceclinicalcourseandriskfactorforrecurrentpcrpositivityindischargedcovid19patientsinguangzhouchinaaprospectivecohortstudy
AT lifurong incidenceclinicalcourseandriskfactorforrecurrentpcrpositivityindischargedcovid19patientsinguangzhouchinaaprospectivecohortstudy
AT liuhuamin incidenceclinicalcourseandriskfactorforrecurrentpcrpositivityindischargedcovid19patientsinguangzhouchinaaprospectivecohortstudy
AT lujianyun incidenceclinicalcourseandriskfactorforrecurrentpcrpositivityindischargedcovid19patientsinguangzhouchinaaprospectivecohortstudy
AT zhoujiyuan incidenceclinicalcourseandriskfactorforrecurrentpcrpositivityindischargedcovid19patientsinguangzhouchinaaprospectivecohortstudy
AT yangziying incidenceclinicalcourseandriskfactorforrecurrentpcrpositivityindischargedcovid19patientsinguangzhouchinaaprospectivecohortstudy
AT yuanyuxin incidenceclinicalcourseandriskfactorforrecurrentpcrpositivityindischargedcovid19patientsinguangzhouchinaaprospectivecohortstudy
AT leichunliang incidenceclinicalcourseandriskfactorforrecurrentpcrpositivityindischargedcovid19patientsinguangzhouchinaaprospectivecohortstudy
AT wuxianbo incidenceclinicalcourseandriskfactorforrecurrentpcrpositivityindischargedcovid19patientsinguangzhouchinaaprospectivecohortstudy